GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Cash Receipts from Operating Activities

MDBIF (TrivarX) Cash Receipts from Operating Activities : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Cash Receipts from Operating Activities?

TrivarX's Cash Receipts from Operating Activities for the six months ended in Dec. 2023 was $0.00 Mil.

TrivarX's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


TrivarX Cash Receipts from Operating Activities Historical Data

The historical data trend for TrivarX's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Cash Receipts from Operating Activities Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Receipts from Operating Activities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.97 0.71 0.65 0.59

TrivarX Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Receipts from Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.65 - - -

TrivarX Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of TrivarX's Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Industry
Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Medibio finalizes acquisition of Vital Conversations

By Marketwired Marketwired 04-12-2018

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Receives CE Certification

By Marketwired Marketwired 05-03-2018

Medibio Market Update

By Marketwired Marketwired 11-02-2018

Medibio Submits FDA De Novo Application

By Marketwired Marketwired 07-16-2018

Medibio Limited Quarterly ASX Update and Cashflows

By Marketwired Marketwired 10-30-2018